Bacteria News and Research

RSS

Level of bacteria on fresh produce can vary according to income level: Study

No one wants a mixed salad tossed with extra bacteria, mold and yeast, but those are just what you might find when you try to eat a healthier diet in poorer neighborhoods. A new study shows that the level of bacteria found on the fresh produce can vary according to the income level of the neighborhoods where it is for sale.

9 Apr 2010

Effective compound against antibiotic-resistant biofilms

Researchers at North Carolina State University have found a chemical compound that, when used in conjunction with conventional antibiotics, is effective in destroying biofilms produced by antibiotic-resistant strains of bacteria such as the Staphylococcus strain MRSA and Acinetobacter. The compound also re-sentsitizes those bacteria to antibiotics.

9 Apr 2010

Triclosan antibacterial found in soap in the spotlight

If a chemical is banned in other countries and by the European Union, it does merit a study by the FDA, even if there is no existing study to suggest that it is harmful to humans. While there may be no current evidence available that triclosan is hazardous to humans, it has been linked to hormone alterations in animals.

9 Apr 2010

Tangent introduces Medix T22 point-of-care terminal for patients and practitioners

Tangent Inc., today announced the Medix T22, a medical grade, point-of-care terminal with a sharp and clear 22-inch wide-screen TFD display.

8 Apr 2010

Hospital TV remotes are potential reservoir of bacteria

According to RID (Committee to Reduce Infection Deaths) over thirty billion dollars is spent each year in the US on hospital-acquired infections. (Infections caught while hospitalized). These very preventable infections cost an additional $15,000.00 on average per patient infected and kill more people in this country than AIDS, breast cancer and car accidents combined.

8 Apr 2010

Nutritional supplement can increase blood circulation of hematopoietic stem cells

A nutritional supplement could stimulate the production of stem cells integral for repairing the body. Research published in BioMed Central's open access Journal of Translational Medicine suggests that a commercially-available supplement can increase the blood circulation of hematopoietic stem cells, which can give rise to all blood cells, and endothelial progenitor cells, which repair damage to blood vessels.

8 Apr 2010

DNA barcoding-sequencing of gene in sand flies identifies two species carrying Leishmania naiffi

In the first survey of sand flies in Panama to use genetic barcoding, scientists at the Smithsonian Tropical Research Institute and Gorgas Memorial Laboratories identified 20 sand fly species from Barro Colorado Island. Two species carried Leishmania naiffi, a parasite that causes cutaneous leishmaniasis: persistent, itchy skin lesions. Three species carried Wolbachia, a bacterial parasite of insects that could contribute to a strategy to control the flies and limit disease transmission.

7 Apr 2010

Achaogen announces completion of $56M Series C round of financing

Achaogen, a biopharmaceutical company focused on the discovery and development of innovative broad-spectrum antibiotics to treat life-threatening, multi-drug resistant bacterial infections, today announced the completion of a $56 million Series C round of financing. The round was led by new investor Frazier Healthcare Ventures, and also included new investor Alta Partners.

7 Apr 2010

Jantibody Therapeutics, Pfenex collaborate in production of HSP-avidin fusion proteins

Boston BioCom LLC today announced the successful completion of a collaborative research agreement between its Jantibody Therapeutics LLC subsidiary and Pfenex Inc., resulting in the rapid production of a HSP-avidin fusion protein for the Jantibodies self-assembling vaccines platform.

7 Apr 2010

MicuRx Pharmaceuticals, Cumencor Pharmaceuticals, Pfizer collaborate to develop antibiotics for MDR-TB

MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.

7 Apr 2010

IGRAs effective for detecting confirmed active TB disease: CHEST

New data from a meta-analysis of existing literature published today in CHEST, the official journal of the American College of Chest Physicians, demonstrate that Interferon Gamma Release Assays are superior to the previous standard in diagnostics, the 100+-year-old tuberculin skin test, for detecting confirmed active Tuberculosis disease.

7 Apr 2010

Astrogenetix narrows in on MRSA virulence onboard space shuttle Discovery

Astronauts on board Space Shuttle Discovery (STS-131) activated an experiment this morning as part of the ninth scientific payload for Astrogenetix, an Austin, Texas-based commercial biotech company. Astrogenetix is conducting the International Space Station National Laboratory Pathfinder Vaccine (NLP-V) missions to take advantage of the unique conditions of microgravity to uncover changes in bacteria that can be targeted to create new vaccines and therapeutics.

6 Apr 2010

Electronic nose may help identify asthma in patients: CHEST

New evidence shows that an "electronic nose" containing an array of gas sensors may have the ability to identify asthma in patients. Researchers from Italy compared the diagnostic performance of the electronic nose with lung function tests and fraction of exhaled nitric oxide in seven patients with asthma and seven healthy subjects.

6 Apr 2010

Study: Carbon nanotubes degraded by MPO enzyme induce less inflammation

A team of Swedish and American scientists has shown for the first time that carbon nanotubes can be broken down by an enzyme - myeloperoxidase (MPO) - found in white blood cells.

6 Apr 2010

Scientists show carbon nanotubes can be broken down by MPO

A team of Swedish and American scientists has shown for the first time that carbon nanotubes can be broken down by an enzyme - myeloperoxidase - found in white blood cells. Their discoveries are presented in Nature Nanotechnology and contradict what was previously believed, that carbon nanotubes are not broken down in the body or in nature.

5 Apr 2010

Inflammation has a role to play in premature births and brain injury: Sahlgrenska Academy thesis

Researchers have gone some way to explaining what happens during premature births and how brain injury develops in premature babies. New findings show that inflammation in both the amniotic fluid and the baby's brain has a role to play, reveals a thesis from the Sahlgrenska Academy.

5 Apr 2010

Why is the genome project not yielding results faster?

As the genome projects reaches the 10 year landmark scientists are defending it. While the sequencing of the 3 billion letters in the human DNA took a long time the first draft of the human genome was presented ten years ago. Today it is possible to have your individual DNA mapped in a day and at the low cost of $5,000.

5 Apr 2010

Sherwin-Williams Chemical Coatings forms partnership with Microban International

Sherwin-Williams Chemical Coatings Division is raising the bar for quality coatings by partnering with Microban International, the global leader in built-in antimicrobial protection, to offer select liquid and powder product finishes with Microban(R) antimicrobial protection. Microban(R) protection works continuously to inhibit the growth of bacteria that can cause stain, odor, discoloration and deterioration of the painted surface.

3 Apr 2010

SE5-OH with Natural S-equol supplement appears to be safe for pre- and post-menopausal women

Healthy pre-and post-menopausal Japanese women who took a supplement of SE5-OH containing Natural S-equol, a novel soy germ-based ingredient under development for the management of menopausal symptoms, had measures of reproductive hormones that stayed within normal limits throughout the study.

3 Apr 2010

Researchers explore microbial infection of human cells in space environment

In a first-of-its-kind experiment, the unique conditions of spaceflight will be used to examine how cells remain healthy or succumb to disease, particularly in the face of stress or damage.

3 Apr 2010

Bacteria News and Research

Level of bacteria on fresh produce can vary according to income level: Study

Effective compound against antibiotic-resistant biofilms

Triclosan antibacterial found in soap in the spotlight

Tangent introduces Medix T22 point-of-care terminal for patients and practitioners

Hospital TV remotes are potential reservoir of bacteria

Nutritional supplement can increase blood circulation of hematopoietic stem cells

DNA barcoding-sequencing of gene in sand flies identifies two species carrying Leishmania naiffi

Achaogen announces completion of $56M Series C round of financing

Jantibody Therapeutics, Pfenex collaborate in production of HSP-avidin fusion proteins

MicuRx Pharmaceuticals, Cumencor Pharmaceuticals, Pfizer collaborate to develop antibiotics for MDR-TB

IGRAs effective for detecting confirmed active TB disease: CHEST

Astrogenetix narrows in on MRSA virulence onboard space shuttle Discovery

Electronic nose may help identify asthma in patients: CHEST

Study: Carbon nanotubes degraded by MPO enzyme induce less inflammation

Scientists show carbon nanotubes can be broken down by MPO

Inflammation has a role to play in premature births and brain injury: Sahlgrenska Academy thesis

Why is the genome project not yielding results faster?

Sherwin-Williams Chemical Coatings forms partnership with Microban International

SE5-OH with Natural S-equol supplement appears to be safe for pre- and post-menopausal women

Researchers explore microbial infection of human cells in space environment

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo